AgomAb completed its IPO on Nasdaq, while Sanofi joined a Series D funding round.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AgomAb completed its IPO on Nasdaq, while Sanofi joined a Series D funding round.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Sanofi
French pharmaceutical company
Nothing else this week.